HLF لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا

03
السعر $12.56
القيمة السوقية (الربع الأخير) $1.32B
P/E (سنوي حالي) 8.1
ربح السهم (سنوي حالي) $1.55
الإيرادات (سنوي حالي) $5.20B
عائد التوزيعات 0.00%
ROE (سنوي حالي) -28.9%
D/E الدين/حقوق الملكية (الربع الأخير) -4.2
نطاق 52 أسبوعًا $8–$20

HLF مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك

04
نطاق
أشرطة

تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.

تجزئة الأسهم 2
تاريخ الاستحقاق تقسيم النوع
15 مايو، 2018 2-for-1 أمامي
18 مايو، 2011 2-for-1 أمامي

حول Herbalife Ltd. Common Shares نظرة عامة على الشركة من ويكيبيديا

05 · wikidata

Herbalife Nutrition Ltd., also called Herbalife International, Inc. (with a U.S. subsidiary called Herbalife International of America) or simply Herbalife, is an American multinational multi-level marketing (MLM) corporation that develops and sells dietary supplements.

The company was founded by Mark R. Hughes in 1980, and employs an estimated 9,900 people worldwide. The company operates in 95 countries through a network of approximately 4.5 million independent distributors and members. In October 2022, previous CEO Michael O. Johnson was appointed as chairman and interim chief executive officer following the departure of John Agwunobi. The business is incorporated in the Cayman Islands, a tax haven, with its corporate headquarters located in Los Angeles, California.

Herbalife has been accused of fraudulently operating a pyramid scheme, deceiving distributors about the amount of income they could expect to earn and that most of their income would be made from recruiting additional distributors instead of from selling merchandise. The company agreed to "fundamentally restructure" its compensation and other benefits in the United States to include tying distributor rewards to verifiable sales, and pay a $200 million fine as part of a 2016 settlement with the U.S. Federal Trade Commission (FTC) following these accusations.

According to a 2007 research paper, some products sold by Herbalife have caused acute hepatitis.

History

In February 1980, Mark R. Hughes began selling the original Herbalife weight management product from the trunk of his car. Hughes often stated that the genesis of his product and program stemmed from the weight loss concerns of his mother Joanne whose premature death he attributed to an eating disorder and an unhealthy approach to weight loss. His first product was a protein shake designed to help people manage their weight. He structured his company using a direct-selling, multi-level marketing model.

In 1982, Herbalife received complaints from the Food and Drug Administration for claims made about certain products and the inclusion of mandrake, poke root, and food-grade linseed oil in another.

The Department of Justice of Canada filed criminal charges against the company in November 1984 for misleading medical claims in advertisements. As a result of the complaints, the company modified its product claims and reformulated the product.

By 1985, Herbalife was considered the fastest-growing private company in America by Inc. after its sales increased from $386 thousand to $423 million over the previous five years. That same year, the California Attorney General sued the company for making inflated claims about the efficacy of its products. The company suffered as a result of the lawsuit and was forced to lay off nearly 800 employees by May 1985. The company settled the suit for $850,000 without admitting wrongdoing.

In 1986, Herbalife became a publicly traded company on the NASDAQ and rebranded itself as Herbalife International. However, as a result of the negative publicity from the FDA lawsuit, the company posted a $3 million loss that year.

By 1988, the company had expanded its reach to Japan, Spain, New Zealand, Israel, and Mexico, and it increased its worldwide sales to $191 million in 1991.

In 1993, the company underwent a secondary offering of five million shares.

The company launched a line of personal care products in 1995 which included fragrances and facial cleansing products.

The company was sued in civil court by two former distributors in 1997 for withholding earned income.

In 1999, Hughes attempted to take the company private after asserting that Wall Street was undervaluing it. While the board approved the buyout offer, shareholders of the company filed a suit against the company because they believed the share price they were offered was unfair. Hughes eventually abandoned his attempt to buy the company and settled the suit with shareholders. On May 20, 2000, Mark Hughes died at age 44. Following his death, the company was led by Christopher Pair until October 2001.

In March 2026, Herbalife acquired Bioniq, a UK-based personalized supplements company that uses blood biomarker analysis to formulate products, for up to US$150 million.

J.H. Whitney & Company and Golden Gate Capital

In 2002, the company was acquired for US$685 million by J.H. Whitney & Company and Golden Gate Capital. Concurrently, plant sources of ephedrine were removed from Herbalife products in 2002 after several U.S. states banned supplements containing such herbs.

In April 2003, Michael O. Johnson joined Herbalife as CEO following a 17-year career with The Walt Disney Company.

On December 16, 2004, the company had an initial public offering on the NYSE of 14.5 million common shares at $14 per share, netting the owners $1.3 billion.

On May 7, 2014, the company announced that it entered into a deal with Bank of America Merrill Lynch to repurchase $266 million of its stock.

The company announced in November 2016 that Chief Operating Officer Richard Goudis would take over the position of CEO in June 2017 and Johnson would transition to Executive Chairman.

In August 2017, the company announced that it would repurchase up to $600 million of its stock.

On April 25, 2018, Herbalife announced that it had changed its name from Herbalife Ltd. to Herbalife Nutrition Ltd. The company also announced that its shareholders had approved a two-for-one stock split.

In January 2019, Herbalife announced that it was replacing Goudis after learning of comments he had made before taking over as CEO that were "contrary to the company’s expense-related policies and business practices” and inconsistent with the company's standards and culture". Former CEO Johnson subsequently took over the role on an interim basis.

In March 2020, John Agwunobi was appointed Chief Executive Officer. Agwunobi departed from Herbalife in October 2022 and Michael O. Johnson was appointed Chairman and interim Chief Executive Officer.

In May 2025, Stephan Gratziani was appointed Chief Executive Officer, becoming the first distributor since founder Mark Hughes to lead the company. Michael O. Johnson transitioned in the position of Executive Chairman.

Products

Herbalife Nutrition's products include weight-loss and protein shakes, as well as protein bars, teas, aloes, vitamins, and sports hydration, energy, and personal care products. The company's original product is the Formula 1 protein shake, a soy-based meal-replacement shake. The product debuted in 1980 and, as of 2015, was the company's best selling product accounting for nearly 30% of total sales.

Herbalife's products are produced at the company's five manufacturing facilities in the U.S. and China, as well as by third-party manufacturing partners. The company's production process is based on a "seed to feed" strategy, which the company initiated in the 2010s that allows it to trace where the ingredients in its nutritional products originated. Since 2013, the company has operated a botanical extraction facility in Changsha, Hunan Province, China. The facility produces botanical extracts, including teas, guarana, chamomile, broccoli, and bilberry, for use in many of the company's products. Before extracts are processed, they undergo a botanical identification program and are tested several times throughout the production process. The processed raw materials from the extraction facility are used at all of the company's branded manufacturing facilities as well as by its partners. As of 2015, 58% of the company's nutrition products were manufactured at Herbalife-owned facilities.

In China, the company's manufacturing sites are located in Suzhou and Nanjing. In the U.S., the company has manufacturing facilities in Lake Forest, California, and Winston-Salem, North Carolina.

Herbalife's claims of health benefits from its products have met scrutiny from the medical community, consumers, and government agencies.

In 2008, Herbalife was sued after laboratory tests indicated that levels of lead in several Herbalife products were in excess of California state law and could lead to liver problems over an extended period of time. The company commissioned its own lab testing and found that those products did not contain high enough amounts of lead to require special labeling.

Business model

Herbalife Nutrition is a multi-level marketing company. A 2010 article in the Los Angeles Business Journal claimed that Herbalife Nutrition was one of the most profitable companies in Los Angeles County and directly benefited from its business model.

As a result of the 2016 FTC settlement, the company is required to prove that at least 80 percent of its sales are made to individuals outside of its distributor network. Distributors are responsible for providing receipts for sales and proving they have legitimate customers. The settlement also required that distributors are only able to earn one-third of their rewards based on recruitment. In the U.S., the company now differentiates between individuals who join as a member to buy discounted products and those who join as a distributor seeking a business opportunity. Discount buyers are unable to earn rewards or sell products. Herbalife Nutrition is also required to have its practices monitored by an outside party for seven years to ensure compliance.

In the past, company management considered the number and retention of distributors a key parameter and tracked it closely in financial reports. By January of each year, sales leaders are required to requalify. In February of each year, individuals who did not satisfy the sales leader qualification requirements during the preceding 12 months are removed from that rank. For the latest 12-month requalification period ending January 2019, approximately 67.9 percent of the eligible sales leaders requalified.

In a California class action suit (Minton v. Herbalife International, et al.) filed on February 17, 2005, the plaintiff challenged "the marketing practices of certain Herbalife International independent distributors under various state laws". In a West Virginia class action suit (Mey v. Herbalife International, Inc., et al.) filed on July 16, 2003, the plaintiffs alleged that some of Herbalife International's distributors used pre-recorded telephone messages and autodialers to contact prospective customers in violation of the Telephone Consumer Protection Act. The case was resolved with Herbalife and its distributors paying $7 million into a fund for class members part of the suit.

Liver disease inquiries

Hospitals in Israel, Spain, Switzerland, Iceland, Argentina, and the United States have reported liver damage in a number of patients who used Herbalife products.

In 2004, Israel's Health Minister began an investigation into Herbalife's products after four persons using Herbalife's products were found to have liver problems. The company was criticized for the presence of lead and other heavy metals in some of its products, with comfrey specifically flagged for its association with liver toxicity. The products were sent to Bio-Medical Research Design LTD (B.R.D), to a private U.S. laboratory, and to Israel's Forensic research laboratory. A study of the cases funded by the Israeli Ministry of Health concluded that there was a causative relationship. Herbalife's SEC 10-Q filings stated that the Israeli Ministry of Health did not establish a causal relationship between the product and liver ailments. In 2009, an Israeli woman sued Herbalife International and Herbalife Israel, claiming that her liver damage resulted from the use of Herbalife products.

Scientific studies in 2007 by doctors at the University Hospital of Bern in Switzerland and the Liver Unit of the Hadassah-Hebrew University Medical Center in Israel found an association between consumption of Herbalife products and hepatitis. In response, the Spanish Ministry of Health issued an alert asking for caution in consuming Herbalife products. Herbalife stated they were cooperating fully with Spanish authorities, and after investigation, the agency determined no action was required and removed the alert.

In January 2009, the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) reached the same conclusion. After reviewing cases implicating Herbalife products in Spain, Switzerland, Israel, Finland, France, Italy, Iceland and Portugal, the 12-member scientific panel issued a report concluding: "The analyses of these cases and information regarding their circumstances have not allowed us to establish a causal relationship" between liver anomalies and Herbalife's dietary supplements. The panel attributed the cases to metabolic changes from overzealous and unsupervised dieting.

A July 2013 peer-reviewed study published in the World Journal of Hepatology reexamined known cases of hepatotoxicity that had previously been linked to consumption of Herbalife products and concluded that using "the liver specific Council for International Organizations of Medical Sciences scale, causality was probable in 1 case, unlikely and excluded in the other cases. Thus, causality levels were much lower than hitherto proposed". In a separate review published less than a year earlier, the same author described the relationship between Herbalife products and reported hepatotoxicity cases as "highly probable".

In 2019, the Journal of Clinical and Experimental Hepatology published a paper titled "Slimming to the Death: Herbalife-Associated Fatal Acute Liver Failure-Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India". This paper examined the connection between Herbalife slimming products and a case of fatal acute liver failure in one patient in India. In December 2020, the journal retracted the aforementioned article, contrary to the COPE guidelines, which advise that the original paper should remain available but prominently marked as retracted. According to one of the co-authors of the paper, this retraction happened because Herbalife engaged DSK Legal, a New Delhi–based law firm, to consistently issue legal threats to the journal's editor-in-chief.

Pyramid scheme allegations

Critics of the company's structure have contended that it has operated as a pyramid scheme. They have also argued that the company does not sufficiently work to curb abuses by individual distributors, though Herbalife Nutrition has consistently denied the allegations.

A 2004 settlement resolved a class-action suit on behalf of 8,700 former and current distributors who accused the company and distributors of "essentially running a pyramid scheme". A total of $6 million was to be paid out, with defendants not admitting guilt.

In November 2011, the Commercial Court in Brussels, Belgium, ruled that Herbalife was an illegal pyramid scheme. The company filed an appeal on March 8, 2012. On December 3, 2013, a Belgian appeals court found for Herbalife, reversing the lower court's finding.

On May 1, 2012, a short seller, David Einhorn, asked questions about the company's business and sales models during the Q1 earnings call, setting off suspicions that Einhorn had a short position. These suspicions were proved correct in January 2013 when at an investor meeting Einhorn revealed that he had profited through a short position against the company. Einhorn said the short had been closed before the end of 2012.

Bill Ackman and Carl Icahn

On December 20, 2012, Bill Ackman (of Pershing Square Capital) presented a series of arguments outlining why his firm believed that Herbalife operated a "sophisticated pyramid scheme" and contended that its stock would hit zero. Ackman alleged after a year-long investigation that the majority of distributors lose money, that the chance of making the testimonial-implied headline income is approximately one in five thousand, and that the company materially overstates its distributors' retail sales and understates their recruiting rewards.

In January 2013, Carl Icahn, investor and founder of Icahn Capital Management, disclosed that he had taken a stake in Herbalife, although he initially declined to publicly state whether he had taken a long position on the stock. Around the same time, Icahn criticized Ackman’s public campaign against the company, alluding to a previous legal dispute between the two stemming from a 2003 stock-sale agreement.

On January 25, 2013, Ackman and Icahn engaged in an on-air exchange on CNBC’s Halftime Report after Icahn called into the show where Ackman was already appearing as a guest. During the 27-minute long exchange, Icahn accused Ackman of orchestrating a bear raid on Herbalife for his own financial gain and called him "a major loser", while Ackman defended his research into the company and argued that Icahn had pursued similar short-selling tactics earlier in his career. The confrontation, drew widespread attention as one of the most discussed moments in financial television history. While the segment aired, trading volume on the New York Stock Exchange reportedly fell more than 20%.

According to a number of financial commentators, Ackman bet roughly $1 billion against the company; soon after remarks to the press, the price of the stock decreased such that Ackman would have made $300 million if he had closed his short position then. In March 2015, federal prosecutors and the FBI revealed that they were investigating whether or not individuals paid by Ackman and otherwise had made false statements about Herbalife's business model to regulators and others in order to lower the company's stock price and influence authorities to conduct an investigation.

In November 2017, Ackman closed out his short position after Herbalife shares increased by 51 percent over the year, and replaced it with a less aggressive put option. In March 2018, The Wall Street Journal reported that Ackman had "largely exited" his bet against the company, while others reported that the bet against Herbalife had cost his company hundreds of millions of dollars and damaged the confidence of investors in his hedge fund.

FTC investigation

Based on information from a Freedom of Information Act (FOIA) request, the New York Post reported on February 4, 2013, that Herbalife was subject to a pending probe from the Federal Trade Commission (FTC). The FTC released 729 pages containing 192 complaints received over a seven-year period in regards to the New York Post's FOIA request. The FTC stated that the wording in its response to the FOIA request was incorrect; the FTC could not confirm or deny an investigation into Herbalife.

In March 2014, the FTC opened an investigation into Herbalife in response to calls from consumer groups and members in both houses of the United States Congress. Herbalife responded to the probe by saying it "welcomes the inquiry given the tremendous amount of misinformation in the marketplace, and will cooperate fully with the FTC. We are confident that Herbalife is in compliance with all applicable laws and regulations". However, in the press conference, Herbalife was declared not necessarily not a pyramid scheme.

In July 2016, Herbalife agreed to modify its business model and pay $200 million in a settlement with the FTC. Partial refund checks were mailed to roughly 350,000 Herbalife distributors in January 2017. The FTC said in a press release about the settlement "it's virtually impossible to make money selling Herbalife products."

The lawsuit alleged Herbalife deceived consumers into believing they could earn substantial income from the business opportunity or big money from the retail sale of the company's products. In addition, the complaint charged that one of the fundamental principles of Herbalife's business model—incentivizing distributors to buy products and to recruit others to join and buy products so they could advance in the company's marketing program, rather than in response to actual consumer demand—is an unfair practice in violation of the FTC Act.

The company remained under investigation as of early 2019 both by the United States Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) for corruption in China.

On September 27, 2019, the SEC announced Herbalife agreed to pay $20 million to settle charges of making false and misleading statements about its business model and operations in China between 2012 and 2018. The company did not admit or deny the charges but agreed to the settlement terms.

U.S. Department of Justice investigation of bribery in China

In 2019, the DOJ charged two of Herbalife's employees with conspiracy in violation of the Foreign Corrupt Practices Act (FCPA). They were accused of bribing Chinese officials to procure sales permits and influence an investigation into Herbalife. They were also accused of offering bribes to China Economic Net to influence media coverage. In response, Herbalife committed $40 million to resolve the issues, and began negotiations with both the DOJ and SEC. In August 2020, Herbalife agreed to pay $123 million to the DOJ and the U.S. Securities and Exchange Commission.

Sports sponsorships

Herbalife has sponsored France's national volleyball team and the Major League Soccer club LA Galaxy since 2007 and has sponsored Cristiano Ronaldo since 2013. They sponsored FC Barcelona and Lionel Messi between 2010 and 2013. Herbalife has also sponsored the basketball club Herbalife Gran Canaria since 2012. In July 2020, Herbalife also sponsored the Guangzhou Charge of the Overwatch League. In addition to these team and player sponsorships, Turkish Women's Basketball Super League has been named 'Herbalife Nutrition Women's Basketball Super League' for three years starting the 2019-2020 regular season.

During the 2020 Summer Olympics, Herbalife Nutrition was a sponsor of the Olympic Committee of Israel and the Indian Olympic Association. In 2023, Herbalife became a sponsor of the Indian Premier League.

In 2023, the company became the main shirt sponsor of the Western Sydney Wanderers FC women's football team.

Herbalife has also sponsored Indian cricket star and former captain Virat Kohli since 2011-2025. They have also sponsored other Indian athletes including Smriti Mandhana, Manika Batra, Lakshya Sen, and Palak Kohli.

Media

In April 2016, a documentary directed by Ted Braun, titled Betting on Zero, premiered at the Tribeca Film Festival. It explored the allegation from Bill Ackman that Herbalife was a pyramid scheme and personal stories of its distributors who lost their life savings. Hilary Rosen, a Democratic lobbyist and an adviser to Herbalife, questioned Tribeca's credibility after claiming that the film was "bought and paid" for by Ackman "to make good on his stock bet".

In 2016, a Last Week Tonight with John Oliver segment on multi-level marketing focused on Herbalife; it strongly condemned the company for its structure resembling a pyramid scheme and cited the FTC report, which implied the company had been operating illegitimately. Oliver criticized Herbalife for its exploitation of Latino communities, and overstatement of its products' health benefits. One reviewer wrote that it appeared to be largely based on Betting on Zero, and caused no immediate change in Herbalife's stock prices.

The 2018 book When The Wolves Bite: Two Billionaires, One Company, and an Epic Wall Street Battle by Scott Wapner discusses Ackman's short of the company and his battle with Carl Icahn. In the book, Wapner characterizes Ackman's decision to bet against Herbalife as dangerous, because it anticipated that the government would shut Herbalife down.

المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗

Wikidata ↗

قطاعConsumer products صناعةConsumer products موظفون8500 بلدKY

أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم

06
الإيرادات$5.04B
2016-12-31 → 2025-12-31
ربح السهم$2.20
2016-12-31 → 2025-12-31
التدفق النقدي الحر$253M
2016-12-31 → 2025-12-31
هامش صافي3.2%
2016-12-31 → 2025-12-31
التقييم والنسب 07–12

التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟

المقياس اتجاه 5 سنوات HLF متوسط 5 سنوات متوسط الأقران الحكم
P/E (سنوي حالي) 8.1متوسط 5 سنوات ≈6.8 ≈6.8 · ·
السعر/المبيعات (سنوي حالي) 0.3متوسط 5 سنوات ≈0.3 ≈0.3 · ·
السعر / القيمة الدفترية (الربع الأخير) -2.8متوسط 5 سنوات ≈-1.8 ≈-1.8 · ·
EV / EBITDA 6.1متوسط 5 سنوات ≈7.6 ≈7.6 · ·
السعر / التدفق النقدي الحر (سنوي حالي) 4.1متوسط 5 سنوات ≈7.4 ≈7.4 · ·
السعر / التدفق النقدي (سنوي حالي) 3.4متوسط 5 سنوات ≈4.7 ≈4.7 · ·
EV / Revenue (القيمة المؤسسية / الإيرادات) 0.6متوسط 5 سنوات ≈0.7 ≈0.7 · ·
EV / FCF (القيمة المؤسسية / التدفق النقدي الحر) 11.6متوسط 5 سنوات ≈16.4 ≈16.4 · ·
السعر / القيمة الدفترية الملموسة (الربع الأخير) -1.6 · · ·

يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.

القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط

التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات

13
عائد الأرباح0.00%
العائد السنوي≈$0.60مدفوع ربع سنويًا
تاريخ الاستحقاقالمبلغالعملةالعائد
فبراير 28, 2014$0,15USD≈1.8%
نوفمبر 7, 2013$0,15USD≈1.9%
أغسطس 9, 2013$0,15USD≈1.8%
مايو 10, 2013$0,15USD≈2.8%
مارس 1, 2013$0,15USD≈3.0%
نوفمبر 9, 2012$0,15USD≈2.6%
أغسطس 10, 2012$0,15USD≈2.2%
مايو 11, 2012$0,15USD≈2.4%
مارس 5, 2012$0,15USD≈1.2%
نوفمبر 9, 2011$0,10USD≈1.1%
أغسطس 11, 2011$0,10USD≈0.99%
مايو 20, 2011$0,05USD≈0.91%
مارس 4, 2011$0,06USD≈1.2%
نوفمبر 10, 2010$0,06USD≈1.4%
أغسطس 10, 2010$0,06USD≈1.5%
مايو 6, 2010$0,05USD≈1.7%
فبراير 26, 2010$0,05USD≈2.0%
نوفمبر 23, 2009$0,05USD≈1.8%
أغسطس 26, 2009$0,05USD≈2.6%
مايو 20, 2009$0,05USD≈2.9%

سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي

14
متوسط المفاجأة 21.4%
التقرير القادم نوفمبر 03, 2026
الفترةتقريرEPS ActualEPS المتوقعالمفاجأة
30 يونيو، 2026 أغسطس 4, 2026 $0.51 $0.54 -5.8%
31 مارس، 2026 $0.64 $0.58 10.5%
31 ديسمبر، 2025 $0.45 $0.43 4.5%
30 سبتمبر، 2025 $0.50 $0.47 7.4%
30 يونيو، 2025 $0.59 $0.39 52.7%
31 مارس، 2025 $0.59 $0.37 59.2%

الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي

15
قائمة الدخل 16
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue $5.04B$4.99B$5.06B$5.20B$5.80B$5.54B$4.88B$4.89B$4.43B$4.49B$4.47B$4.96B
Cost of Revenue $1.11B$1.10B$1.19B$1.17B$1.24B$1.15B$958M$919M$849M$855M$856M$983M
Gross Profit $3.92B$3.89B$3.87B$4.03B$4.56B$4.39B$3.92B$3.97B$3.58B$3.63B$3.61B$3.98B
SG&A Expense $1.66B$1.73B$1.70B$1.81B$2.01B$2.08B$1.94B$1.96B$1.76B$1.97B$1.78B$1.99B
Operating Income $481M$386M$356M$545M$734M$641M$568M$683M$617M$458M$584M$514M
Interest Expense $214M$218M$166M$139M$153M$133M$153M$181M$161M$99M$100M$92M
Interest Income ········$14M$6M$6M$12M
Other Non-op $0$-10M$1M$13M$-25M$0$-16M$-57M$400.0K·$-2M$-13M
Pretax Income $275M$169M$203M$425M$561M$516M$451M$464M$471M$365M$486M$421M
Income Tax $47M$-85M$61M$104M$114M$144M$140M$168M$257M$105M$147M$113M
Net Income $228M$254M$142M$321M$447M$373M$311M$297M$214M$260M$339M$309M
EPS (Basic) $2.22$2.53$1.44$3.26$4.22$2.83$2.26$2.12$1.35$1.57$4.11$3.58
EPS (Diluted) $2.20$2.50$1.42$3.23$4.13$2.77$2.20$1.98$1.29$1.51$3.97$3.40
Shares (Basic) 102,800,000100,600,00099,000,00098,500,000105,900,000131,500,000137,400,000140,200,000158,500,000166,100,00082,600,00086,300,000
Shares (Diluted) 103,600,000101,600,000100,200,00099,500,000108,300,000134,500,000141,600,000149,500,000165,700,000172,200,00085,300,00090,800,000
EBITDA $481M$386M$356M$545M$734M$641M$568M$683M$617M$458M$584M$514M
الميزانية العمومية 28
المقياس اتجاه 202520242023202220212020201920182017201620152014
Cash & Equivalents $353M$415M$575M$508M$602M$1.05B$839M$1.20B$1.28B$844M$890M$645M
Receivables $92M$69M$81M$71M$67M$83M$80M$70M$93M$70M$70M$84M
Inventory $512M$475M$505M$581M$576M$501M$436M$382M$341M$371M$332M$378M
Prepaid Expense $188M$184M$238M$197M$188M$146M$133M$154M$147M$177M$161M$186M
Current Assets $1.14B$1.14B$1.40B$1.36B$1.43B$1.78B$1.49B$1.80B$1.86B$1.46B$1.57B$1.39B
PP&E (Net) $448M$460M$506M$486M$442M$390M$372M$360M$378M$378M$339M$367M
PP&E (Gross) $1.51B$1.48B$1.52B$1.52B$1.46B$1.32B$1.22B$1.13B$1.08B$982M$877M$850M
Accum. Depreciation $1.06B$1.02B$1.01B$1.03B$1.02B$934M$845M$765M$703M$604M$537M$483M
Goodwill $100M$88M$95M$93M$95M$100M$92M$93M$97M$90M$92M$102M
Intangibles $315M$312M$314M$316M$317M$313M$310M$310M$310M$310M$310M$310M
Other Non-current Assets $145M$140M$129M$274M$313M$274M$228M$222M$250M$325M$141M$155M
Total Assets $2.79B$2.73B$2.81B$2.73B$2.82B$3.08B$2.68B$2.79B$2.90B$2.57B$2.48B$2.35B
Accounts Payable $100M$70M$84M$90M$92M$89M$82M$81M$68M$66M$71M$72M
Accrued Liabilities ·········$237M$229M$252M
Current Liabilities $1.01B$1.23B$1.28B$977M$1.08B$1.13B$964M$1.59B$907M$792M$1.02B$875M
Capital Leases $156M$170M$168M$192M$201M$207M$170M·····
Deferred Tax ·····$39M$21M$8M$8M$15M$400.0K$15M
Other Non-current Liabilities $155M$153M$172M$166M$196M$193M$155M$150M$157M$139M$70M$65M
Total Liabilities $3.30B$3.53B$3.87B$4.00B$4.21B$3.93B$3.07B$3.51B$3.23B$2.37B$2.53B$2.69B
Long-term Debt $1.99B$2.26B$2.56B$2.69B$2.76B$2.43B$1.80B$2.45B$2.27B$1.45B$1.62B$1.79B
Total Debt $1.99B$2.26B$2.56B$2.69B$2.76B$2.43B$1.80B$2.45B$2.27B$1.45B$1.62B$1.81B
Common Stock $100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K
Retained Earnings $-580M$-808M$-1.06B$-1.20B$-1.17B$-687M$-215M$-526M$-248M$-66M$-326M$-665M
Treasury Stock ···$0$329M$329M$329M$329M$329M···
AOCI $-252M$-271M$-232M$-250M$-212M$-182M$-212M$-210M$-165M$-205M$-166M$-78M
Stockholders' Equity $-515M$-801M$-1.06B$-1.27B$-1.39B$-856M$-390M$-723M$-335M$196M$-54M$-334M
Liabilities + Equity $2.79B$2.73B$2.81B$2.73B$2.82B$3.08B$2.68B$2.79B$2.90B$2.57B$2.48B$2.35B
Shares Outstanding 103,300,000101,200,00099,200,00097,900,000100,800,000120,100,000137,400,000142,800,000164,700,000186,300,00092,700,00092,200,000
التدفق النقدي 16
المقياس اتجاه 202520242023202220212020201920182017201620152014
D&A $121M$121M$113M$115M$108M$100M$98M$100M$100M$98M$98M$93M
Stock-based Comp $44M$50M$48M$44M$54M$51M$39M$36M$42M$40M$45M$46M
Deferred Tax $-64M$-230M$-41M$-30M$-33M$2M$15M$-8M$98M$-36M$-38M$-85M
Amort. of Intangibles ···········$300.0K
Restructuring $7M$69M··········
Operating Cash Flow $333M$285M$358M$352M$460M$629M$458M$648M$591M$367M$629M$511M
CapEx $80M$122M$135M$156M$151M$112M$106M$84M$96M$143M$79M$174M
Investing Cash Flow $-109M$-85M$-135M$-156M$-156M$-123M$-108M$-84M$-95M$-142M··
Stock Repurchased $8M$8M$11M$147M$1.01B$924M$17M$750M$844M$13M$17M$1.29B
Net Stock Activity $-8M$-8M$-11M$-147M$-1.01B$-924M$-17M$-750M$-844M$-13M$-17M$-1.29B
Dividends Paid ·······$0$0$0$0$30M
Financing Cash Flow $-296M$-335M$-148M$-265M$-729M$-321M$-713M$-593M$-85M$-252M··
Net Change in Cash $-63M$-157M$79M$-94M$-444M$206M$-368M$-80M$439M$-48M$244M$-328M
Taxes Paid $117M$132M$121M·········
Free Cash Flow $253M$163M$222M$196M$309M$517M$351M$564M$495M$224M$550M$338M
Levered FCF $75M$-164M$106M$91M$187M$421M$246M$449M$422M$153M$480M·
الربحية 8
المقياس اتجاه 202520242023202220212020201920182017201620152014
Gross Margin 77.9%77.9%76.5%77.5%78.6%79.2%80.4%81.2%80.8%81.0%80.8%80.2%
Operating Margin 9.6%7.7%7.0%10.5%12.7%11.6%11.7%14.0%13.9%10.2%13.1%10.4%
Net Margin 4.5%5.1%2.8%6.2%7.7%6.7%6.4%6.1%4.8%5.8%7.6%6.2%
Pretax Margin 5.5%3.4%4.0%8.2%9.7%9.3%9.3%9.5%10.6%8.1%10.9%8.5%
EBITDA Margin 9.6%7.7%7.0%10.5%12.7%11.6%11.7%14.0%13.9%10.2%13.1%10.4%
ROA 8.3%9.2%5.1%11.6%15.2%13.0%11.4%10.4%7.8%10.3%14.0%12.7%
ROE -34.7%-27.7%-13.1%-24.4%-32.8%-42.1%-72.5%-40.0%-309.1%364.2%-174.8%284.5%
ROIC 27.0%39.7%16.6%28.9%42.7%29.4%27.7%25.2%14.5%19.9%25.9%25.5%
السيولة والملاءة 5
المقياس اتجاه 202520242023202220212020201920182017201620152014
Current Ratio 1.10.91.11.41.31.61.51.12.11.81.51.6
Quick Ratio 0.40.40.50.60.61.01.00.81.51.20.90.8
Debt / Equity -3.9-2.8-2.4-2.1-2.0-2.8-4.6-3.4-6.87.4-30.3-5.4
LT Debt / Equity -3.8-2.5-2.1-2.1-2.0-2.8-4.6-2.5-6.57.3-26.0-5.1
Interest Coverage 2.21.82.13.94.84.83.73.83.84.65.8·
الكفاءة 3
المقياس اتجاه 202520242023202220212020201920182017201620152014
Asset Turnover 1.81.81.81.92.01.91.81.71.61.81.82.0
Inventory Turnover 2.32.32.22.02.32.52.32.52.42.42.42.7
Receivables Turnover 62.766.566.775.777.368.064.959.754.164.058.253.9
لكل سهم 6
المقياس اتجاه 202520242023202220212020201920182017201620152014
Book Value / Share $-4.99$-7.92$-10.69$-12.93$-13.80$-7.13$-2.84$-5.07$-4.07$2.11$-0.58$-3.63
Revenue / Share $48.62$49.14$50.52$52.31$53.58$41.20$34.44$32.72$53.41$52.13$52.39$54.61
Cash Flow / Share $3.22$2.81$3.57$3.54$4.25$4.67$3.23$4.34$7.13$4.27$7.37$5.63
Cash / Share $3.42$4.10$5.80$5.19$5.97$8.70$6.11$8.40$15.54$9.07$9.60$7.00
Dividend / Share ···········$0.30
EPS (TTM) $2.20$2.50$1.42$3.23$4.13$2.77$2.20$1.98$1.29$1.51$3.97$3.40
معدلات النمو 9
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue YoY 0.89%-1.4%-2.7%-10.3%4.7%·······
Revenue CAGR 3Y -1.1%-4.9%-3.0%·········
Revenue CAGR 5Y -1.9%···········
EPS YoY -12.0%76.1%-56.0%-21.8%49.1%·······
EPS CAGR 3Y -12.0%-15.4%-20.0%·········
EPS CAGR 5Y -4.5%···········
Net Income YoY -10.2%78.8%-55.7%-28.1%20.0%·······
Net Income CAGR 3Y -10.8%-17.2%-27.5%·········
Net Income CAGR 5Y -9.3%···········
التقييم (آخر 12 شهرًا) 16
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue TTM $5.04B$4.99B$5.06B$5.20B$5.80B$5.54B$4.88B$4.89B$4.43B$4.49B$4.47B$4.96B
Net Income TTM $228M$254M$142M$321M$447M$373M$311M$297M$214M$260M$339M$309M
Market Cap $1.33B$677M$1.51B$1.46B$4.13B$5.77B$6.55B$8.42B$2.79B$2.24B$2.49B$1.74B
Enterprise Value $2.97B$2.52B$3.50B$3.64B$6.29B$7.15B$7.51B$9.67B$3.78B$2.84B$3.22B$2.90B
P/E 5.92.710.74.69.917.321.729.826.215.96.85.5
P/S 0.30.10.30.30.71.01.31.70.60.50.60.4
P/B -2.6-0.8-1.4-1.2-3.0-6.7-16.8-11.6-8.311.4-46.5-5.2
P / Cash Flow 4.02.44.24.19.09.214.313.04.76.14.03.4
P / FCF 5.34.16.87.413.411.218.614.95.610.04.55.1
EV / EBITDA 6.26.59.86.78.611.213.214.26.16.25.55.7
EV / FCF 11.715.415.718.620.413.821.417.17.612.75.98.6
EV / Revenue 0.60.50.70.71.11.31.52.00.90.60.70.6
Dividend Yield 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.8%
Earnings Yield 17.1%37.4%9.3%21.7%10.1%5.8%4.6%3.4%3.8%6.3%14.8%18.0%
Payout Ratio ·······0.00%0.00%0.00%0.00%9.8%
Annual Payout $0$0$0$0$0$0$0$0$0$0$0$30M

أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·

القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات

16
المقياس 2025-12-312024-12-312023-12-312022-12-312021-12-31
الإيرادات $5.04B $4.99B $5.06B $5.20B $5.80B
هامش الربح الإجمالي % 77.9% 77.9% 76.5% 77.5% 78.6%
هامش الربح التشغيلي % 9.6% 7.7% 7.0% 10.5% 12.7%
صافي الدخل $228M $254M $142M $321M $447M
EPS المخفف $2.20 $2.50 $1.42 $3.23 $4.13

الملاك المؤسسيون (13F) 267 مقدمي إقرار · $1.6B إجمالي · حتى تاريخ 30 سبتمبر، 2026

17

المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.

حائزون 267
القيمة المحتفظ بها $1.6B
مراكز جديدة 34
المراكز الخارجة 42
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
مراكز جديدة المراكز الخارجة زيادة انخفض صافي التغير في الأسهم
34 (-28 مقابل الربع السابق) 42 (+8 مقابل الربع السابق) 101 (+16 مقابل الربع السابق) 72 (-11 مقابل الربع السابق) +3.2M

مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.

مؤسسة القيمة الأسهم % من 13F المتتبعة النوع
VANGUARD GROUP INC $150970258 11712200 9,70% الأسهم
BlackRock, Inc. $110079260 8371046 7,07% الأسهم
Route One Investment Company, L.P. $109786720 8348800 7,06% الأسهم
Nantahala Capital Management, LLC $86790000 6600000 5,58% عقد خيار الشراء
VANGUARD PORTFOLIO MANAGEMENT LLC $81428443 6192277 5,23% الأسهم
RENAISSANCE TECHNOLOGIES LLC $66074384 5024668 4,25% الأسهم
VANGUARD CAPITAL MANAGEMENT LLC $58016485 4411900 3,73% الأسهم
GEODE CAPITAL MANAGEMENT, LLC $45572279 3465068 2,93% الأسهم
Solel Partners LP $37452712 2848115 2,41% الأسهم
STATE STREET CORP $33478164 2545868 2,15% الأسهم
FMR LLC $33210818 2525538 2,13% الأسهم
TWO SIGMA INVESTMENTS, LP $30743240 2337889 1,98% الأسهم
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $29752204 2262525 1,91% الأسهم
CITADEL ADVISORS LLC $28811650 2191000 1,85% عقد خيار البيع
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $27830844 2116414 1,79% الأسهم
IRIDIAN ASSET MANAGEMENT LLC/CT $27329382 2078280 1,76% الأسهم
DIMENSIONAL FUND ADVISORS LP $24789162 1885302 1,59% الأسهم
Quantedge Capital Pte Ltd $24273427 1845888 1,56% الأسهم
GOLDMAN SACHS GROUP INC $23494014 1786617 1,51% الأسهم
Long Focus Capital Management, LLC $22344480 1699200 1,44% الأسهم
CITIGROUP INC $18410000 1400000 1,18% عقد خيار الشراء
CITIGROUP INC $18167804 1381582 1,17% الأسهم
VICTORY CAPITAL MANAGEMENT INC $16357588 1243923 1,05% الأسهم
Caption Management, LLC $15780000 1200000 1,01% عقد خيار الشراء
Penn Capital Management Company, LLC $15069481 1145024 0,97% الأسهم
Nantahala Capital Management, LLC $14585375 1109154 0,94% الأسهم
Tenzing Global Management, LLC $13150000 1000000 0,85% الأسهم
NORTHERN TRUST CORP $12887960 980073 0,83% الأسهم
TWO SIGMA ADVISERS, LP $12019925 932500 0,77% الأسهم
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $11797786 897170 0,76% الأسهم
CITADEL ADVISORS LLC $11022330 838200 0,71% عقد خيار الشراء
FIRST TRUST ADVISORS LP $10198574 775557 0,66% الأسهم
MORGAN STANLEY $9560707 727049 0,61% الأسهم
VANGUARD FIDUCIARY TRUST CO $9024227 686253 0,58% الأسهم
NEW YORK STATE COMMON RETIREMENT FUND $8941579 679968 0,57% الأسهم
Qube Research & Technologies Ltd $8218487 624980 0,53% الأسهم
Aristotle Capital Boston, LLC $7466962 567829 0,48% الأسهم
PANAGORA ASSET MANAGEMENT INC $7361817 559834 0,47% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $7131245 542300 0,46% عقد خيار الشراء
MILLENNIUM MANAGEMENT LLC $6408639 487349 0,41% الأسهم
Nuveen, LLC $6180343 469988 0,40% الأسهم
Invesco Ltd. $6081375 462462 0,39% الأسهم
Manatuck Hill Partners, LLC $6039269 459260 0,39% الأسهم
JPMORGAN CHASE & CO $5900411 461330 0,38% الأسهم
Bank of New York Mellon Corp $5842280 444280 0,38% الأسهم
Squarepoint Ops LLC $5633144 428376 0,36% الأسهم
CIBC Bancorp USA Inc. $5616602 427118 0,36% الأسهم
Johnson Financial Group, LLC $5451859 414590 0,35% الأسهم
Lombard Odier Asset Management (USA) Corp $5292875 402500 0,34% عقد خيار الشراء
Trexquant Investment LP $5265773 400439 0,34% الأسهم

عرض جميع الملاك المؤسسيين البالغ عددهم 267 →

الناشطون والمالكون بنسبة 5%+ 23 حيازة

18

المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.

مقدم مقدم حصة الحالة الغرض إيداع
Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×3 إيداعات 6 مايو، 2021 · إيداع أولي · SEC
5 نوفمبر، 2020 · إيداع أولي · SEC
12 أغسطس، 2020 · إيداع أولي · SEC
High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×14 إيداعات 30 أكتوبر، 2019 · إيداع أولي · SEC
25 مايو، 2018 · إيداع أولي · SEC
20 مارس، 2018 · إيداع أولي · SEC
21 أغسطس، 2017 · إيداع أولي · SEC
24 مارس، 2014 · إيداع أولي · SEC
14 مارس، 2014 · إيداع أولي · SEC
William P. Stiritz ×2 إيداعات 30 يناير، 2014 · إيداع أولي الهيكل الرأسمالي SEC
Whitney V, L.P., Whitney Strategic Partners V, L.P., Whitney Equity Partners V, LLC ×4 إيداعات 4 مايو، 2007 · إيداع أولي · SEC
19 إبريل، 2007 · إيداع أولي · SEC
19 إبريل، 2007 · إيداع أولي · SEC
9 إبريل، 2007 · إيداع أولي · SEC
9 إبريل، 2007 · إيداع أولي · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

المطلعون على الشركة 95 من المطلعين · مسؤولون 35 · مديرون 41

19
مطلع الدور آخر نشاط الأسهم المملوكة مشتريات 12 شهرًا مبيعات 12 شهرًا صافي 12 شهرًا
Stephan Paulo Gratziani Chief Executive Officer 3 مايو، 2026 F 107310 0 0 $0
John O Agwunobi Chairman and CEO 10 مايو، 2022 P 134745 0 0 $0
Richard Goudis Chief Executive Officer 17 سبتمبر، 2018 M 861213 0 0 $0
John Desimone Chief Financial Officer 25 فبراير، 2026 A 241144 0 0 $0
Alexander Amezquita Chief Financial Officer 3 مارس، 2024 F 152042 0 0 $0
Robert Levy President 4 مايو، 2026 F 11405 0 0 $0
Gregory Probert President & COO 4 إبريل، 2008 A 158086 0 0 $0
Brian Kane President - Europe 14 أكتوبر، 2005 M 651442 0 0 $0
Troy Hicks Chief Operating Officer 18 مايو، 2026 M 9706 0 2 $-619415
Mark J Schissel Chief Operating Officer 7 إبريل، 2023 F 185090 0 0 $0
David Pezzullo Chief Operating Officer 26 فبراير، 2021 F 170316 0 0 $0
Jehangir D Irani SVP, Chief Accounting Officer 4 مايو، 2026 F 46371 0 0 $0
Henry C Wang Chief Legal Officer 4 مايو، 2026 F 142514 0 0 $0
Ibelis Montesino EVP & Chief of Staff 3 مايو، 2024 A 160812 0 0 $0
Stephen Conchie Regional Pres. APAC & China 4 مايو، 2023 A 81793 0 0 $0
Edi Hienrich Regional Pres. EMEA & India 4 مايو، 2023 A 34361 0 0 $0
Alan L Hoffman EVP, Global Corporate Affairs 17 مايو، 2022 P 57218 0 0 $0
Thomas Harms SVP, China & APAC 26 فبراير، 2021 F 30509 0 0 $0
Jesus Alzarez VP, General Manager, Mexico 9 مارس، 2018 S 2085 0 0 $0
Jossie Aspauza VP, SAM/CAM 5 مارس، 2018 M 6546 0 0 $0
Calero Miguel Angel Fernandez EVP, The Americas & WWD Ops 12 مايو، 2017 S 0 0 0 $0
Jerry Li SVP, Managing Director, China 11 مايو، 2017 S 0 0 0 $0
Gioji Okuhara VP, General Manager, Brazil 23 فبراير، 2017 A · 0 0 $0
Mark J Friedman General Counsel 23 فبراير، 2017 A 3916 0 0 $0
William Rahn SVP / Mg Dir. - Asia Pacific 11 فبراير، 2015 A 0 0 0 $0
Brett Chapman Chief Legal Officer 12 أغسطس، 2014 P 300 0 0 $0
Patricio Cuesta SVP/Managing Director SAM 22 يوليو، 2014 M 8643 0 0 $0
Thomas Zimmer SVP, North America 30 نوفمبر، 2010 A 11935 0 0 $0
Yair Steve Henig Chief Scientific Officer 1 أكتوبر، 2010 M 9776 0 0 $0
David Wynne Roberts SVP - EMEA 29 يوليو، 2009 A 14829 0 0 $0
Mora Adriana Gabriela Mendizabal SVP - Mexico & Central America 2 إبريل، 2009 A 19175 0 0 $0
Eneida Bini Senior Vice President, Brazil 31 مارس، 2008 M 1437 0 0 $0
Percy Chin SVP, Greater China 29 مايو، 2007 A 3265 0 0 $0
Sergio Medina Gomez SVP, Mexico & Central America 24 مايو، 2007 M 416 0 0 $0
John Purdy Regional Director Asia Pacific 8 مايو، 2006 M 56200 0 0 $0
Sophie L'Helias مدير 4 يونيو، 2026 P 79882 3 0 $29020
Rodica Macadrai مدير 8 مايو، 2026 A 67441 0 0 $0
Perkins Miller مدير 8 مايو، 2026 A 50769 0 0 $0
Juan Miguel Mendoza مدير 8 مايو، 2026 A 181879 0 0 $0
Lynda Cloud مدير 8 مايو، 2026 A 50736 1 0 $152490
Maria Otero مدير 8 مايو، 2026 A 95129 0 0 $0
Donal Mulligan مدير 8 مايو، 2026 A 68982 0 0 $0
Richard H Carmona مدير 8 مايو، 2026 A 83645 0 0 $0
Des Walsh مدير 8 مايو، 2026 A 61879 0 0 $0
Michael J Levitt مدير 8 مايو، 2026 A 49393 0 0 $0
Michael Johnson مدير 25 فبراير، 2026 A 887415 0 0 $0
Celine Del Genes مدير 2 مايو، 2025 A 55818 0 0 $0
Alan W Lefevre مدير 3 مايو، 2024 A 69117 0 0 $0
Kevin M. Jones مدير 4 مايو، 2023 A 19589 0 0 $0
John Tartol مدير 9 ديسمبر، 2022 P 321793 0 0 $0
James Larry Nelson مدير 1 سبتمبر، 2020 S 18959 0 0 $0
Hernandez Margarita Palau مدير 11 مايو، 2020 A 8486 0 0 $0
Jesse Lynn مدير 11 مايو، 2020 A 24674 0 0 $0
Hunter Clark Gary مدير 11 مايو، 2020 A 24674 0 0 $0
Nick Graziano مدير 11 مايو، 2020 A 8486 0 0 $0
Michael Montelongo مدير 11 مايو، 2020 A 20674 0 0 $0
Jeff Dunn مدير 9 مايو، 2019 M 62135 0 0 $0
Pedro Cardoso مدير 28 فبراير، 2018 M 18168 0 0 $0
Richard P Bermingham مدير 28 فبراير، 2018 M 4253 0 0 $0
Keith Cozza مدير 8 مايو، 2017 A 8094 0 0 $0
Leroy Barnes مدير 15 يوليو، 2014 M 2000 0 0 $0
Colombe M Nicholas مدير 6 يناير، 2014 M 3810 0 0 $0
Carole Black مدير 19 ديسمبر، 2013 A 8000 0 0 $0
Murray H Dashe مدير 29 فبراير، 2012 S 3000 0 0 $0
Lawrence M Higby مدير 11 مارس، 2011 S 1000 0 0 $0
Leon Waisbein مدير 20 نوفمبر، 2008 P 369091 0 0 $0
Hal Gaba مدير 12 نوفمبر، 2008 P 22484 0 0 $0
Valeria Rico مدير 15 يناير، 2008 A 8190 0 0 $0
Peter Maslen مدير 15 يناير، 2008 A 8804 0 0 $0
Peter M Castleman مدير 3 مايو، 2007 J 0 0 0 $0
Halbert David مدير 15 يناير، 2007 A 5650 0 0 $0
Charles Orr مدير 15 يناير، 2006 A 10242 0 0 $0
Kenneth Diekroeger مدير 13 ديسمبر، 2005 S 10409411 0 0 $0
Markus Lehmann مدير 31 أغسطس، 2005 S 552841 0 0 $0
Leslie Stanford مدير 15 ديسمبر، 2004 P 1333477 0 0 $0
ICAHN CARL C مالك 10% 30 مايو، 2018 S 35227904 0 0 $0
Jesse Rogers مالك 10% 7 فبراير، 2007 S 0 0 0 $0
David Dominik مالك 10% 7 فبراير، 2007 S 173155 0 0 $0
Michael R Stone مالك 10% 22 ديسمبر، 2005 J 35000 0 0 $0
Brien Daniel J O مالك 10% 19 ديسمبر، 2005 J 146143 0 0 $0
Robert M Williams JR مالك 10% 19 ديسمبر، 2005 J 146143 0 0 $0
Paul R Vigano مالك 10% 19 ديسمبر، 2005 J 146143 0 0 $0
Steven E Rodgers مالك 10% 19 ديسمبر، 2005 J 146143 0 0 $0
John C Hockin مالك 10% 19 ديسمبر، 2005 J 146143 0 0 $0
William Laverack JR مالك 10% 19 ديسمبر، 2005 J 146143 0 0 $0
Frank Lamberti · 4 أغسطس، 2026 F 34914 0 2 $-1932264
Jonathan Christodoro · 11 ديسمبر، 2020 M 26349 0 0 $0
Shin-Shing Bosco Chiu · 26 فبراير، 2020 F 28963 0 0 $0
Paul Noack · 17 أكتوبر، 2008 M 59681 0 0 $0
WHITNEY EQUITY PARTNERS V LLC · 3 مايو، 2007 J 0 0 0 $0
WHITNEY STRATEGIC PARTNERS V LP · 3 مايو، 2007 J 0 0 0 $0
WHITNEY PRIVATE DEBT FUND LP · 3 مايو، 2007 J 0 0 0 $0
WHITNEY V LP · 3 مايو، 2007 J 0 0 0 $0
Henry Burdick · 2 مايو، 2005 A · 0 0 $0
GREEN RIVER OFFSHORE FUND LTD · 30 مارس، 2005 J 0 0 0 $0

المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط

ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 31 صناديق مؤشرات متداولة

20

الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.

صندوق الوزن الوحدات حتى تاريخ المصدر
PSL · Invesco Exchange-Traded Fund Trust 1,50% 94361 SH 2 أكتوبر، 2026 يومي
VFVA · VANGUARD WELLINGTON FUND 0,20% 130114 SH 19 أغسطس، 2026 يومي
VDC · VANGUARD WORLD FUND 0,17% 1192598 SH 19 أغسطس، 2026 يومي
VFMO · VANGUARD WELLINGTON FUND 0,09% 138764 SH 19 أغسطس، 2026 يومي
PRFZ · Invesco Exchange-Traded Fund Trust 0,08% 181765 SH 2 أكتوبر، 2026 يومي
VTWV · VANGUARD SCOTTSDALE FUNDS 0,08% 84830 SH 19 أغسطس، 2026 يومي
IWM · iShares Trust 0,04% 2655278 SH 11 سبتمبر، 2026 يومي
RSSL · Global X Funds 0,04% 49026 NS 31 يوليو، 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,04% 590862 SH 19 أغسطس، 2026 يومي
VBR · VANGUARD INDEX FUNDS 0,03% 1431032 SH 19 أغسطس، 2026 يومي
DFAS · Dimensional ETF Trust 0,03% 321616 NS 31 يوليو، 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,02% 1189647 SH 19 أغسطس، 2026 يومي
VB · VANGUARD INDEX FUNDS 0,02% 2264109 SH 19 أغسطس، 2026 يومي
WSML · iShares Trust 0,01% 7584 SH 11 سبتمبر، 2026 يومي
NEAR · iShares U.S. ETF Trust 0,01% 471000 SH 10 سبتمبر، 2026 يومي
DFSU · Dimensional ETF Trust 0,01% 12198 NS 31 يوليو، 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 11675 NS 31 يوليو، 2026 N-PORT
IWO · iShares Trust 0,00% 48248 SH 11 سبتمبر، 2026 يومي
DFAC · Dimensional ETF Trust 0,00% 145548 NS 31 يوليو، 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 25109 NS 31 يوليو، 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 35205 NS 31 يوليو، 2026 N-PORT
ITOT · iShares Trust 0,00% 138695 SH 11 سبتمبر، 2026 يومي
IWV · iShares Trust 0,00% 29142 SH 8 سبتمبر، 2026 يومي
DXUV · Dimensional ETF Trust 0,00% 665 NS 31 يوليو، 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 3123063 SH 19 أغسطس، 2026 يومي
VTWG · VANGUARD SCOTTSDALE FUNDS 0,00% 5506 SH 19 أغسطس، 2026 يومي
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 8659 SH 19 أغسطس، 2026 يومي
IWN · iShares Trust · 912957 SH 11 سبتمبر، 2026 يومي
ISCB · iShares Trust · 4583 SH 11 سبتمبر، 2026 يومي
ISCV · iShares Trust · 22098 SH 11 سبتمبر، 2026 يومي
SMLF · iShares Trust · 204558 SH 11 سبتمبر، 2026 يومي

HLF توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود

21
تصنيف · 8 محللين شراء
السعر المستهدف الوسيط $17.00 +35,4%
3 37,5% شراء قوي
3 37,5% شراء
1 12,5% احتفاظ
1 12,5% بيع
0 0,0% بيع قوي

السعر المستهدف لمدة 12 شهرًا

3 محللين · 2026-10-03

السعر المستهدف المتوسط $17.00 +35,4%

الآن السعر الحالي $12.56
منخفض$9.00 المتوسط$17.00 مرتفع$25.00

آخر الأخبار أحدث العناوين التي تذكر هذه الشركة

23

مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة

26

اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.

يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.

المصدر: إيداع SEC 10-Q بتاريخ أغسطس 5, 2026